Percutaneous coronary intervention (PCI): CE marked indications for Terumo Ultimaster

Important news from interventional cardiology. Ultimaster, DES-Drug-Eluting Stent produced by Terumo, Gada’s partner, has achieved 16 CE marked indications for (link to news): ACS, STEMI, NSTEMI, DAPT, diabetes, MVD, SV, LL, elderly, ISR, CTO, bifurcation, women, men, ostial injuries and LM.

Used for percutaneous coronary interventions (PCI), Ultimaster is one of the DES with the most of clinical indications approved. CE marked indications confirm positive results achieved in clinical trials, as Century II, that have approved safety and efficacy of the Terumo device.